ORFADIN
NDC 66658-204, nitisinone, suspension, from Swedish Orphan Biovitrum AB (publ).
- Product NDC
- 66658-204
- Status
- Listed
- Labeler
- Swedish Orphan Biovitrum AB (publ)
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA206356
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66658-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NITISINONE4 mg/mL
Pharmacologic classes
4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 2E1 Inducers [MoA]; Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]; Organic Anion Transporter 1 Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66658-204-90 | 66658020490 | 1 BOTTLE, GLASS in 1 CARTON (66658-204-90) / 90 mL in 1 BOTTLE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/00307f42-748d-4227-8c6f-ed5f0a89ae0a
Use it
Look up 66658-204 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66658-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66658-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.